2. Academic Validation
  3. [Pharmacological, pharmacokinetic, and clinical profile of palonosetron hydrochloride (ALOXI I.V. Injection 0.75 mg), a novel antiemetic 5-HT3-receptor antagonist]

[Pharmacological, pharmacokinetic, and clinical profile of palonosetron hydrochloride (ALOXI I.V. Injection 0.75 mg), a novel antiemetic 5-HT3-receptor antagonist]

  • Nihon Yakurigaku Zasshi. 2010 Aug;136(2):113-20. doi: 10.1254/fpj.136.113.
Hirofusa Ajioka 1,  Fumio Morita,  Yushiro Akizawa,  Kenichiro Yoshida,  Ryuichi Kitamura,  Hisami Takimoto
Affiliations

Affiliation

PMID: 20702972 DOI: 10.1254/fpj.136.113
Figures
Products